Previous Article | Next Article ![]()
Applied and Environmental Microbiology, November 2008, p. 6697-6702, Vol. 74, No. 21
0099-2240/08/$08.00+0 doi:10.1128/AEM.00925-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Martin Haslbeck,2 and
Dirk Weuster-Botz1*
Lehrstuhl für Bioverfahrenstechnik, Technische Universität München, Boltzmannstr. 15, 85748 Garching, Germany,1 Lehrstuhl Biotechnologie, Technische Universität München, Lichtenbergstr. 4, 85748 Garching, Germany2
Received 23 April 2008/ Accepted 4 September 2008
A new ketoreductase useful for asymmetric synthesis of chiral alcohols was identified in the cyanobacterium Synechococcus sp. strain PCC 7942. Mass spectrometry of trypsin-digested peptides identified the protein as 3-ketoacyl-[acyl-carrier-protein] reductase (KR) (EC 1.1.1.100). The gene, referred to as fabG, was cloned, functionally expressed in Escherichia coli, and subsequently purified to homogeneity. The enzyme displayed a temperature optimum at 44°C and a broad pH optimum between pH 7 and pH 9. The NADPH-dependent KR was able to asymmetrically reduce a variety of prochiral ketones with good to excellent enantioselectivities (>99.8%). The KR showed particular high specific activity for asymmetric reduction of ethyl 4-chloroacetoacetate (38.29 ± 2.15 U mg–1) and 2',3',4',5',6'-pentafluoroacetophenone (8.57 ± 0.49 U mg–1) to the corresponding (S)-alcohols. In comparison with an established industrial enzyme like the alcohol dehydrogenase from Lactobacillus brevis, the KR showed seven-times-higher activity toward 2',3',4',5',6'-pentafluoroacetophenone, with a remarkably higher enantiomeric excess (>99.8% [S] versus 43.3% [S]).
Published ahead of print on 12 September 2008.
Present address: TÜV SÜD Product Service GmbH, MHS2—Nonactive Medical Devices, Ridlerstr. 65, 80339 Munich, Germany.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»